Equities
  • Price (EUR)59.78
  • Today's Change-1.08 / -1.77%
  • Shares traded12.39k
  • 1 Year change-32.11%
  • Beta--
Data delayed at least 20 minutes, as of Aug 12 2022 18:11 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.

  • Revenue in EUR (TTM)1.63bn
  • Net income in EUR82.35m
  • Incorporated2007
  • Employees10.80k
  • Location
    Gerresheimer AGKlaus-Bungert-Strasse 4DUESSELDORF 40468GermanyDEU
  • Phone+49 211618100
  • Fax+49 2 116181295
  • Websitehttps://www.gerresheimer.com/
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.